Advanced search
Publication Cover
Clinical Toxicology Volume 52, 2014 - Issue 9
Submit an article Journal homepage
22,622
Views
118
CrossRef citations to date
0
Altmetric
Review Article

Treatment for calcium channel blocker poisoning: A systematic review

M. St-OngeOntario and Manitoba Poison Centre, Toronto, ON, Canada;Institute of Medical Science, University of Toronto, Toronto, ON, Canada;Department of Clinical Pharmacology and Toxicology, University of Toronto, Toronto, ON, CanadaCorrespondence[email protected]
,
P.-A. DubéDirection of Environmental Health and Toxicology, Institut national de santé publique du Québec, Québec, QC, Canada;Centre Hospitalier Universitaire de Québec, Québec, QC, Canada;Faculty of Pharmacy, Université Laval, Québec, QC, Canada
,
S. GosselinCentre antipoison du Québec, Québec, QC, Canada;Department of Medicine, McGill University, Montréal, QC, Canada;Toxicology Consulting Service, McGill University Health Centre, Montréal, QC, Canada
,
C. GuimontCentre Hospitalier Universitaire de Québec, Québec, QC, Canada
,
J. GodwinOntario and Manitoba Poison Centre, Toronto, ON, Canada;Department of Clinical Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada
,
P. M. ArchambaultCentre de santé et services sociaux Alphonse-Desjardins (CHAU de Lévis), Lévis, QC, Canada;Department of Family Medicine and Emergency Medicine, Université Laval, Québec, QC, Canada;Division de soins intensifs, Université Laval, Québec, QC, Canada;Populations Health and Optimal Health Practices, Centre Hospitalier Universitaire de Québec Research Centre, Québec, QC, Canada
,
J.-M. ChaunyHôpital du Sacré-Coeur de Montréal, Montréal, QC, Canada;Department of Family and Emergency Medicine, University of Montreal, Montréal, QC, Canada
,
A. J. FrenetteHôpital du Sacré-Coeur de Montréal, Montréal, QC, Canada;Faculty of Pharmacy, University of Montreal, Montréal, QC, Canada
,
M. DarveauPharmacy Department, Centre de santé et services sociaux Alphonse-Desjardins (CHAU de Lévis), Lévis, QC, Canada
,
N. Le sageCentre Hospitalier Universitaire de Québec, Québec, QC, Canada;Populations Health and Optimal Health Practices, Centre Hospitalier Universitaire de Québec Research Centre, Québec, QC, Canada
,
J. PoitrasCentre de santé et services sociaux Alphonse-Desjardins (CHAU de Lévis), Lévis, QC, Canada;Department of Family Medicine and Emergency Medicine, Université Laval, Québec, QC, Canada
,
J. ProvencherInstitut universitaire de Cardiologie et de Pneumologie de Québec, Québec, QC, Canada
,
D. N. JuurlinkOntario and Manitoba Poison Centre, Toronto, ON, Canada;Sunnybrook Research Institute and Institute for Clinical Evaluative Sciences, Toronto, ON, Canada;Departments of Medicine and Pediatrics, University of Toronto, Toronto, ON, Canada
&
R. BlaisCentre antipoison du Québec, Québec, QC, Canada
 show all
Pages 926-944 | Received 20 Nov 2013, Accepted 10 Sep 2014, Published online: 06 Oct 2014

References

  • Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Dart RC. 2011 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th annual report. Clin Toxicol 2012; 50:911–1164.
  • St-Onge M, Archambault P, LeSage N, Guimont C, Poitras J, Blais R. Adherence to calcium channel blocker poisoning treatment recommendations in two Canadian cities. Clin Toxicol 2012; 50:424–430.
  • Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction - GRADE evidece profiles and summary of findings tables. J Clin Epidemiol 2011; 64:383–394.
  • The AGREE Next Steps Consortium. Appraisal of Guidelines for Research and Evaluation II, May 2009, 56pp.
  • Dekkers OM, Egger M, Altman DG, Vandenbroucke JP. Distinguishing case series from cohort studies. Ann Intern Med 2012; 156:37–40.
  • Lavergne V, Nolin TD, Hoffman RS, Roberts D, Gosselin S, Goldfarb DS, et al. The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: Guideline methodology. Clin Toxicol 2012; 50:403–413.
  • Higgins JPR, Altman DG, Gotzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343:d5928.
  • von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61:344–349.
  • National Collaborating Centre for Methods and Tools (2008). Quality Assessment Tool for Quantitative Studies, Hamilton, ON: McMaster University. (Updated 13 April, 2010). Retrieved from http://www.nccmt.ca/registry/view/eng/14.html.
  • Moga C, Guo B, Schopflocher D, Harstall C. Development of a Quality Appraisal Tool for Case Series Studies Using a Modified Delphi Technique. Edmonton AB: Institute of Health Economics 2012.
  • Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. PLoS Biology 2010; 8:e1000412.
  • Institute of Medicine and National Research Council of National Academies, Dietary supplements, a framework for evaluating safety, The National Academies. Washington DC 2005, pp. 506 (p.165).
  • Gadow KA, Sprenger KB. Successful plasmapheresis in severe diltiazem poisoning. Dtsch Med Wochenschr 1995; 120:1023–1024.
  • Gutschmidt HJ. Successful plasmapheresis in severe diltiazem poisoning. Dtsch Med Wochenschr 1995; 120:81–82.
  • Oliver TB, Awupor-Reoner C. Isoprenaline infusion and right ventricular pacing in severe diltiazem poisoning. N Z Med J 1992; 105:483.
  • Kandil A, Karras S, Hamed MR. Effect of calcium on acute toxicity of verapamil. J Drug Res 1984; 15:121–125.
  • Pap I, Kertesz J, Sagi I. Attempted suicide with verapamil. Orv Hetil 1989; 130:735–736.
  • Samtleben W. Successful plasmapheresis in severe diltiazem poisoning. Dtsch Med Wochenschr 1995; 120:1023.
  • Musselman M, Farber M, Smolinkse S, Aaron C. A comparison of high dose insulin therapy and conventional inotropic therapy in calcium channel blocker and/or beta-blocker toxic ingestions. Ann Emerg Med 2011; 58:S325.
  • Bryant SM, Espinoza TR, Aks SE. Seven years of high dose insulin therapy for calcium channel antagonist poisoning. Clin Toxicol 2009; 47:751.
  • Greene SL, Gawarammana I, Wood DM, Jones AL, Dargan PI. Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective study. Intensive Care Med 2007; 33:2019–2024.
  • Masson R, Colas V, Parienti JJ, Lehoux P, Massetti M, Charbonneau P, et al. A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation 2012; 83:1413–1417.
  • Lo JC, Ubaldo C, Cantrell FL. A retrospective review of whole bowel irrigation in pediatric patients. Clin Toxicol 2012; 50:414–417.
  • Belson MG, Gorman SE, Sullivan K, Geller R. Calcium channel blocker ingestions in children. Am J Emerg Med 2000; 18:581–586.
  • Barrow PM, Houston PL, Wong DT. Overdose of sustained-release verapamil. British J Anaesthesia 1994; 72:361–365.
  • Lambert H, Weber M, Renaud D. Intoxications aiguës par diltiazem. Bilan des centres anti-poisons français. J Toxicol Clin Exp 1990; 10:229–42.
  • Sauder P, Kopferschmitt J, Dahlet M, Tritsch L, Flesch F, Siard P, et al. Acute verapamil poisoning. 6 cases. Review of the literature. J Toxicol Clin Exp 1990; 10:261–270.
  • Cumpston KL, Aks SE, Sigg T, Pallasch E. Whole bowel irrigation and the hemodynamically unstable calcium channel blocker overdose: primum non nocere. J Emerg Med 2010; 38:171–174.
  • Buckley N, Dawson AH, Whyte IM. Slow-release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium. Med J Aust 1993; 158:202–204.
  • Madera F, Wenger R. About intoxication with Isoptin S (verapamil and pentobarbital). Intensivmedizin 1977; 14:373–377.
  • Espinoza T, Bryant SM, Aks SE. Hyperinsulin therapy for calcium channel antagonist poisoning: a seven-year retrospective study. Am J Ther 2013; 20:29–31.
  • Holger JS, Stellpflug SJ, Cole JB, Harris CR, Engebretsen KM. High-dose insulin: a consecutive case series in toxin-induced cardioganic shock. Clin Toxicol 2011; 49:653–658.
  • Boyer EW, Duic PA, Evans A. Hyperinsulinemia/euglycemia therapy for calcium channel blocker poisoning. Pediatr Emerg Care 2002; 18:36–37.
  • Boyer EW, Shannon M. Treatment of calcium-channel-blocker intoxication with insulin infusion. N Engl J Med 2001; 344:1721–1722.
  • Yuan TH, Kerns WP II, Tomaszewski CA, Ford MD, Kline JA. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol 1999; 37:463–474.
  • Engebretsen KM, Morgan MW, Stellpflug SJ, Cole JB, Anderson CP, Holger JS. Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcomes. Clin Toxicol 2010; 48:806–812.
  • Kline JA, Raymon RM, Leonova ED, Williams TC, Watts JA. Insulin improves heart function and metabolism during non-ischemic cardiogenic shock in awake canines. Cardiovasc Res 1997; 34:289–298.
  • Kline JA, Leonova E, Williams TC, Schroeder JD, Watts JA. Myocardial metabolism during graded intraportal verapamil infusion in awake dogs. J Cardiovasc Pharmacol 1996; 27:719–726.
  • Kline JA, Tomaszewski C, Schroeder JD, Raymon RM. Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthethetized canine. J Pharmacol Exp Ther 1993; 267:744–750.
  • Graudins A, Wong KK. Comparative hemodynamic effects of levosimendan alone and in conjunction with 4-aminopyridine or calcium chloride in a rodent model of severe verapamil poisoning. J Med Toxicol 2010; 6:85–93.
  • Graudins A, Najafi J, Rur-SC MP. Treatment of experimental verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity. Clin Toxicol 2008; 46:50–56.
  • Strubelt O, Diederich KW. Studies of antidote therapy for nisoldipine intoxication in experimental animals. Arzneimittelforschung 1990; 40:747–751.
  • Gay R, Algeo S, Lee R, Olajos M, Morkin E, Goldman S. Treatment of verapamil toxicity in intact dogs. J Clin Invest 1986; 77:1805–1811.
  • Strubelt O, Diederich KW. Experimental investigations on the antidotal treatment of nifedipine overdosage. J Toxicol Clin Toxicol 1986; 24:135–149.
  • Strubelt O. Antidotal treatment of the acute cardiovascular toxicity of verapamil. Acta Pharmacol Toxicol 1984; 55:231–237.
  • Vick JA, Kandil A, Herman EH, Balazs T. Reversal of proprabolol and verapamil toxicity by calcium. Vet Hum Toxicol 1983; 25:8–10.
  • Konca C, Yildizdas RD, Sari MY, Yükselmis U, Horoz OO, Yilmaz HL. Evaluation of children poisoned with calcium channel blocker or beta blocker drugs. Turk Arch Ped 2013; 48:138–144.
  • Supradip G, Mrinal S. Calcium channel blocker overdose: experience with amlodipine. Indian J Crit Care Med 2008; 12:190–193.
  • Karti SS, Ulusoy H, Yandi M, Gunduz A, Kosucu M, Erol K, Ratip S. Non-cardiogenic pulmonary oedema in the course of verapamil intoxication. Emerg Med J 2002; 19:458–459.
  • Howarth DM, Dawson AH, Smith AJ, Buckley N, Whyte IM. Calcium channel blocking drug overdose: an Australian series. Hum Exp Toxicol 1994; 13:161–166.
  • Parikka H, Pohjola-Sintonen S, Rapola J, Sipila R, Luomanmaki K. Calcium channel blocker poisoning. Duodecim 1993; 109:687–695.
  • Ramoska EA, Spiller HA, Winter M, Borys D. A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment. Ann Emerg Med 1993; 22:196–200.
  • Roper TA, Sykes R, Gray C. Fatal diltiazem overdose: report of four cases and review of the literature. Postgrad Med J 1993; 69:474–476.
  • Bausch R, Dirschedl P, Fahrenkrog U, Loellgen H. Clinical observations of calcium-channel-blocker intoxication. Intensive Med 1991; 28:120–123.
  • Horowitz BZ, Rhee KJ. Massive verapamil ingestion: a report of two cases and a review of the literature. Am J Emerg Med 1989; 7:624–631.
  • Henry M, Kay MM, Viccellio P. Cardiogenic shock associated with calcium-channel and beta blockers: reversal with intravenous calcium chloride. Am J Em Med 1985; 3:334–336.
  • Jaeger A, Sauder P, Bianchetti G, Kopferschmitt J, Dahlet M, Tritsch L, Flesch F. Acute diltiazem poisoning: kinetic and hemodynamic study. J Toxicol Clin Exp 1990; 10:243–248.
  • Rizvi I, Ahmad A. Life-threatening calcium channel blocker overdose and its management. BMJ Case Rep 2012. doi:10.1136/bcr.01.2012.5643.
  • Hasson R, Mulcahy V, Tahir H. Amlodipine poisoning complicated with acute non-cardiogenic pulmonary oedema. BMJ Case Rep 2011. doi:10.1136/bcr.07.2011.4467.
  • Devasahayam J, Pillai U, Uppaluri C. Acute severe intestinal obstruction secondary to amlodipine toxicity. QJM 2012; 105:467–469.
  • Marjanovic VS, Cokanovic V. A case of severe verapamil intoxication. Serbian J Exp Clin Res 2010; 11:33–36.
  • Wills B, Liu M, Wahl M. Third-degree AV block from extended-release diltiazem ingestion in a nine-month old. J Emerg Med 2010; 38:328–331.
  • Felgenhauer EF, Zilker N. Effectiveness of calcium chloride and high dose insulin therapy in a life threatening intentional quinidine and verapamil intoxication. A case report. J Toxicol Clin Toxicol 2004; 42:557–558.
  • Gerloni R, Copetti R. Easily reversible hypoxemia and hypotension induced by nimodipine. Eur J Emerg Med 2004; 11:295–297.
  • Nanda U, Ashish A, Why HJ. Modified release verapamil induced cardiovenic shock. Emerg Med J 2005; 22:832–833.
  • Isbister GK. Delayed asystolic cardiac arrest after diltiazem overdose; resuscitation with high dose intravenous calcium. Emerg Med J 2002; 19:335–357.
  • Lee DW, Cohan B. Refractory cardiogenic shock and complete heart block after verapamil SR and metoprolol treatment. Angiology 1995; 46:517–519.
  • Lipman J, Jardine I, Roos C, Dreosti L. Intravenous Calcium chloride as an antidote to verapamil-induced hypotension. Intensive Care Med 1982; 8:55–57.
  • Woie L, Storstein L. Successful treatment of suicidal verapamil poisoning with calcium gluconate. Eur Heart J 1981; 2:239–242.
  • Moroni F, Manaioni PF, Dolara A, Ciaccheri M. Calcium gluconate and hypertonic sodium chloride in a case of massive verapmil poisoning. Clin Toxicol 1980; 17:395–400.
  • Lam YM, Tse HF, Lau CP. Continuous calcium chloride infusion for massive nifedipine overdose. Chest 2001; 119:1280–1282.
  • Adams BD, Browne WT. Amlodipine overdose causes prolonged calcium channel blocker toxicity. Am J Emerg Med 1998; 16:527–528.
  • Ashraf M, Chaudhary K, Nelson J, Thompson W. Massive overdose of sustained-release verapamil: a case report and review of literature. Am J Med Sci 1995; 310:258–263.
  • Luscher TF, Noll G, Sturmer T, Huser B, Wenk M. Calcium gluconate in severe verapamil intoxication. NEJM 1994; 330:718–720.
  • Perkins CM. Serious verapamil poisoining: treatment with intravenous calcium gluconate. BMJ 1978; 2:1127.
  • Li Saw F, Lip GY. Case report: fatal verapamil overdosage despite intensive therapy and use of high dose intravenous calcium. J Human Hypertens 1996; 10:495–496.
  • Crump BJ, Holt DW, Vale JA. Lack of response to intravenous calcium in severe verapamil poisoning. The Lancet 1982; 23:939–940.
  • Buylaert WA, Callens B, Decruyenaere JM, Koch AR, Verstraete A, Vogelaers DP. Fatal intoxication with amlodipine. J Toxicol Clin Toxicol 1995; 33:253.
  • Barry JD, Durkovich D, Cantrell L, Richardson W, Tong T, Offerman S, et al. Vasopressin treatment of verapamil toxicity in the porcine model. J Med Toxicol 2005; 1:3–10.
  • Kanagarajan K, Marraffa JM, Bouchard NC, Krishman P, Hoffman RS, Stork CM. The use of vasopressin in the setting of recalcitrant hypotension due to calcium channel blocker overdose. Clin Toxicol 2007; 45:56–59.
  • Marraffa JM, Stork CM, Medicis JJ, Hodgman MH, Cantor R. Massive amlodipine overdose successfully treated using high-dose vasopressin. J Toxicol Clin Toxicol 2004; 42:732–733.
  • Levine M, Curry SC, Padilla-Jones A, Ruha AM. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single centre. Ann Emerg Med 2013; 62:252–258.
  • Kandil A, Karras S, Hamed MR. Effect of calcium on acute toxicity of verapamil. J Drug Res 1984; 15:121–125.
  • Groszek B, Szpak D, Klys M, Scislowski M. Acute poisoning with nifedipine and acebutol, two cases. Przegl Lek 2003; 60:262–264.
  • Hagège A, Masquet C, Beaufils P, Slama R. Intoxication massive par le vérapamil à libération prolongée. Arch Mal Coeur 1990; 83:1745–1747.
  • Stone CK, Thomas SH, Koury SI, Low RB. Glucagon and phenylephrine combination vs glucagon alone in experimental verapamil overdose. Acad Emerg Med 1996; 3:120–125.
  • Stone CK, May WA, Carrooll R. Treatment of verapamil overdose with glucagon in dogs. Ann Emerg Med 1995; 25:369–374.
  • Love JN, Sachdeva DK, Curtis LA, Howell JM, Bessman ES. A potential role for glucagon in the treatment of drug-induced sympatomatic bradycardia. Chest 1998; 114:323–326.
  • Doyon S, Roberts JR. The use of glucagon in a calcium channel blocker overdose. Ann Emerg Med 1993; 22:1229–1233.
  • Cohen V, Jellinek SP, Fancher L, Sangwan G, Wakslak M, Marquart E, Farahani C. Tarka (trandolapril/verapamil hydrochloride extended release) overdose. J Emerg Med 2011; 40:291–295.
  • Mahr NC, Valdes A, Lamas G. Use of glucagon for acute intravenous diltiazem toxicity. Am J Cardiol 1997; 79:1570–1571.
  • Love JN, Howell JM. Glucagon therapy in the treatment of symptomatic bradycardia. Ann Emerg Med 1997; 29:181–183.
  • Chu J, Donovan SP, Rolston D, Lepp D, Patel V, Wall E, Bania T. The effect of intravenous lipid emulsions in an oral verapamil toxicity model. Acad Emerg Med 2013; 20:S120.
  • Perichon D, Turfus S, Graudins A. Intravenous lipid emulsion does not improve hemodynamics or survival in a rodent model of oral verapamil poisoning. Clin Toxicol 2013; 51:252–378.
  • Tebbbutt S, Harvey M, Nicholson T, Cave G. Intralipid prolongs survival in a rat model of verapamil toxicity. Acad Emerg Med 2006; 13:134–139.
  • Perez E, Bania TC, Medlej K, Chu J. Determining the optimal dose of intravenous fat emulsion for the treatment of severe verapamil toxicity in a rodent model. Acad Emerg Med 2008; 15:1284–1289.
  • Bania TC, Chu J, Perez E, Su M, Hahn IH. Hemodynamic effects of intravenous fat emulsion in a an animal model of verapamil toxicity resuscitated with atropine. Acad Emerg Med 2007; 14:105–111.
  • Geib AJ, Manini A, Liebelt E. Case series of intravenous lipid emulsion rescue for drug cardiotoxicity. Clin Toxicol 2009; 47:704.
  • West PL, McKeown NJ, Hendrickson RG. Iatrogenic lipid emulsion overdose in a case of amlodipine poisoning. Clin Toxicol 2010; 48:393–396.
  • Magdalan J. New treatment methods in verapamil poisoning: experimental studies. Pol J Pharmacol 2003; 55:425–432.
  • Tuncok Y, Apaydin S, Gelal A, Ates M, Guyen H. The effects of 4-aminopyridine and Bay K 8644 on verapamil-induced cardiovascular toxicity in anesthetized rats. J Toxicol Clin Toxicol 1998; 36:301–307.
  • Plewa MC, Martin TG, Menegazzi JJ, Seaberg DC, Wolfson AB. Hemodynamic effects of 3,4 diaminopyridine in a swine model of verapamil toxicity. Ann Emerg Med 1994; 23:499–507.
  • Korstanje C, Jonkman FA, Van Kemenade JE, Van Zwieten PA. Bay k 8644, a calcium entry promoter, as an antidote in verapamil intoxication in rabbits. Arch Int Parmacodyn Ther 1987; 287:109–119.
  • Agoston S, Maestrone E, van Hezik EJ, Ket JM, Houwertjes MC, Uges DR. Effective treatment of verapamil intoxication with 4-aminopyridine in the cat. J Clin Invest 1984; 73:1291–1296.
  • Wesseling H, Houwertjes MC, de Langen CDJ, Kingma JH. Hemodynamic effects of high dosages of verapamil and the lack of protection by 4-aminopyridine in the rabbit. Arch Int Pharmacodyn Ther 1983; 266:106–112.
  • Fiszer M, Kolacinski Z, Rechcinski T. The application of 4-aminopyridine in calcium channel inhibitors acute poisoning. Przegl Lek 2007; 64:293–297.
  • Magdalan J, Kochman K, Antonczyk A, Przewlocki M, Smolarek M. Successful treatment by 4-aminopyridine of three cases of severe verapamil poisoning. Przegl Lek 2003; 60:271–273.
  • Abraham MK, Scott SB, Meltzer A, Barrueto F Jr. Levosimendan does not improve survival time in a rat model of verapamil toxicity. J Med Toxicol 2009; 5:3–7.
  • Kurola J, Leppikangas H, Magga J, Lindgren L, Kiviniemi V, Rutanen J, Ruokonen E. Effect of levosimendan in experimental verapamil-induced myocardial depression. Scand J Trauma Resusc Emerg Med 2010; 18:12.
  • Varpula T, Rapola J, Sallisalmi M, Kurola J. Treatment of serious calcium channel blocker overdose with levosimendan, a calcium sensitizer. Anesth Analg 2009; 108:790–792.
  • Daubin C, Lehoux P, Ivascau C, Tasle M, Bousta M, Lepage O, et al. Extracorporeal life support in severe drug intoxication: a retrospective cohort study of seventeen cases. Crit Care 2009; 13:R138.
  • Mégarbane B, Leprince P, Deye N, Résière D, Guerrier F, Rettab S, et al. Emergency feasibility in medical intensive care unit of extracorporeal life support for refractory cardiac arrest. Intensive Care Med 2007; 33:758–764.
  • Babatasi G, Massetti M, Verrier V, Lehoux P, LePage O, Bruno PG, Khayat A. Severe intoxication with cardiotoxic drugs: value of emergency percutaneous cardiocirculatory assistance. Arch Mal Coeur Vaiss 2001; 94:1386–1392.
  • Stachon K, Dabek J, Jakubowski D, Rychlik W. Clinical implications in patients after ingestions of excessive doses of calcium channel blockers – our observations. Pol Merk Lek 2011; 31:145–149.
  • Lee DW, Cohan B. Refractory cardiogenic shock and complete heart block after verapamil SR and metoprolol treatment. A case report. Angiology 1995; 46:517–519.
  • McGlinchey PG, McNeill AJ. Drug overdoses requiring temporary cardiac pacing; a study of six cases treated at Altnagelvin Hospital, Londonderry. Ulster Med J 1998; 67:13–18.
  • Beiträge ZK. Suicide attempt with verapamil, Therapiewoche 1984; 34:2483–2491.
  • Immonen P, Linkola A, Waris E. Three cases of severe verapamil poisoning. In J Cardiol 1981; 1:101–105.
  • Gris P, Coffernils M, Alame T, Kimbimbi TP. Intoxication volontaire au vérapamil, à propos d'un cas, revue de la littérature. Sem Hôp Paris 1989; 65:435–438.
  • Snover SW, Bocchino V. Massive diltiazem overdose. Ann Emerg Med 1986; 15:1221–1224.
  • Dogan M, Basaranoglu M, Peker E, Akbayram S, Sahin M, Uner A, Caksen H. Tarka® overdose in a young child. Hum Exp Toxicol 2011; 39:1392–1398.
  • Koury SI, Stone CK, Thomas SH. Amrinone as an antidote in experimental verapamil overdose. Acad Emerg Med 1996; 36:762–767.
  • Tuncok Y, Apaydin S, Kalkan S, Ates M, Guven H. The effects of amrinone and glucagon on verapamil-induced cardiovascular toxicity in anaesthetized rats. In J Exp Path 1996; 77:207–212.
  • Sandroni C, Cavallara F, Addario C, Hamilton RJ. Successful treatment with enoximone for severe poisoning with atenolol and verapamil: a case report. Ann Emerg Med 2005; 46:99.
  • Link A, Hammer B, Weigerber K, Bohm M. Verapamil intoxication: therapy with norepinephrine and the phosphodiesterase inhibitor enoximone. Dtsch Med Wochenschr 2002; 127:2006–2008.
  • Kuhlmann U, Schoenemann H, Muller TF, Keuchel M, Lange H. Plasmapheresis in fatal overdose with verapamil. Intensive Care Med 1999; 25:1473.
  • Ezidiegwu C, Spektor Z, Nasr MR, Kelly KC, Rosales LG. A case report on the role of plasma exchange in the management of a massive amlodipine besylate intoxication. Ther Apher Dial 2008; 12:180–184.
  • Siebenlist D. Plasma separation in verapamil poisoning. Dtsch Med Wochenschr 1990; 115:797.
  • Pichon N, Dugard A, Clavel M, Amiel JB, François B, Vignon P. Extracorporeal albumin dialysis in three cases of acute calcium channel blocker poisoning with life-threatening refractory cardiogenic shock. Ann Emerg Med 2012; 59: 540–544.
  • Belleflamme M, Hantson P, Gougnard T, Minon JM, Wittebole X’ Laterre PF, et al. Survival despite extremely high plasma diltiazem level in a case of acute poisoning treated by the molecular-adsorbent recirculation system. Eur J Emerg Med 2012; 19:59–61.
  • Anthony T, Jastremski M, Elliott W, Morris G, Prasad H. Charcoal hemoperfusion for the treatment of a combined diltiazem and metoprolol overdose. Ann Emerg Med 1986; 15:1344–1348.
  • Rahman O, Craft M, Mainali R, Hartie J. Massive diltiazem overdose treated with continunous veno-venous hemodiafiltration. Crit Care Med 2009; 37:A511.
  • Pfaender M, Casetti PG, Azzolini M, Baldi ML, Vailli A. Successful treatment of a massive atenolol and nifedipine overdose with CVVHDF. Minerva Anesthesiol 2008; 74:97–100.
  • Roberts DM, Roberts JA, Boots RJ, Mason R, Lipman J. Lessons learnt in the pharmacokinetic analysis of the effect of haemoperfusion for acute overdose with sustained-release diltiazem. Anaesthesia 2008; 63:714–718.
  • Rosansky SJ. Verapamil toxicity treatment with hemoperfusion. Ann Int Med 1991; 114:340–341.
  • Janion M, Stepien A, Sielski J, Gutkowski W. Is the intra-aortic balloon pump a method of brain protection during cardiogenic shock after drug intoxication? J Emerg Med 2012; 38:162–167.
  • Laes J, Orozco BS, Cole JB. Use of percutaneous left ventricular assist device (Impella) in vasodilatory poison-induced shock [abstract]. Clin Toxicol 2013; 51:673.
  • Jang DH, Nelson LS, Hoffman RS. Methylene blue in the treatment of refractory shock from an amlodipine overdose. Ann Emerg Med 2011; 58:565–567.
  • Aggarwal N, Kupfer Y, Seneviratne C, Tessler S. Methylene blue reverses recalcitrant shock in beta-blocker and calcium channel blocker overdose. BMJ Case Rep 2013;2013.
  • Kim HK, Hoffman RS, Nelson LS, Jang DH. Methylene blue for refractory hypotension in cardiovascular drug overdose. EAPCCT abstract 2012, p.365.
  • Ramo MP, Grupp I, Pesola MK, Heikkila J, Luomanmaki K, Schroder T, Grupp G. Cardiac glycosides in the treatment of experimental overdose with calcium-blocking agents. Res Exp Med 1992; 192:355–343.
  • Bania TC, Blaufeux B, Hughes S, Almond GL, Homel P. Calcium and digoxin vs calcium alone for severe verapamil toxicity. Acad Emerg Med 2000; 7:1089–1096.
  • Bania TC, Chu J, Almond G, Perez E. Dose-dependent hemodynamic effect of digoxin therapy in severe verapamil toxicity. Acad Emerg Med 2004; 11:221–227.
  • Mottram AR, Bryant SM, Aks SE. Dose dependent response to cyclodextrin infusion in a rat model of verapamil toxicity. West J Emerg Med 2012; 13:63–67.
  • Mottram AR, Bryant SM, Aks SE. Effect of cyclodextrin infusion in a rat model of verapamil toxicity. Am J Ther 2011; 18:371–374.
  • Ozbilgin S, Ozbilgin M, Kucukoztas B, Kamaci G, Unek T, Yurthu BS, et al. Evaluation of the effectiveness of sugammadex for verapamil intoxication. Basic Clin Pharmacol Toxicol 2013; 113:280–285.
  • Bertrand N, Bouvet C, Moreau P, Leroux JC. Transmembrane pH-gradient liposomes to treat cardiovascular drug intoxication. ACS Nano 2010; 4:7552–7558.
  • Forster V, Luciani P, Leroux JC. Treatment of calcium channel blocker-induced cardiovascular toxicity with drug scavenging liposomes. Biomaterials 2012; 33:3578–3585.
  • Tanen DA, Ruha AM, Curry SC, Graeme KA, Reagan CG. Hypertonic sodium bicarbonate is effective in the acute management of verapamil toxicity in a swine model. Ann Emerg Med 2000; 36:547–553.
  • Kalam Y, Graudins A. The effects of fructose-1,6-diphosphate on haemodynamic parameters and survival in a rodent model of propranolol and verapamil poisoning. Clin Toxicol 2012; 50:546–554.
  • Lheureux P, Vranckx M, Leduc D, Askenasi R. Effect of PK11195 on cardiovascular toxicity due to verapamil: an experimental study in the dog. J Toxicol Clin Exp 1990; 10:449–460.
  • Lynch MJ, Katz KD, Callaway CW, Logue ES. Survival of verapamil-poisoned rats treated with triiodothyronine, J Med Toxicol 2010; 6:94–99.
  • Perez E, Chu J, Bania T, Medlej K. L-Carnitine increases survival in a murine model of severe verapamil toxicity. Acad Emerg Med 2011; 18:1136–1140.
  • Chu J, Donovan SP, Lepp D, Rolston D, Patel V, Wall E, Bania T. The effects of increased dosing of L-carnitine in a model of verapamil toxicity. Acad Emerg Med 2013; 20:S119.
  • Donovan SP, Chu J, Wall EL, Patel VC, Rolston DM, Bania TC. The effects of L-Carnitine in a murine model with a higher degree of verapamil toxicity. Clin Toxicol 2012; 50:574–720.
  • Tauro DI, Roy S, Kailuraya M, Mehta RM. Extracorporeal membrane oygenation (ECMO) for amlodipine overdose: a life saving intervention. Chest 2009;136:37S-e–38S.
  • Abeysinghe N, Aston J, Polouse S. Diltiazem overdose: a role for high-dose insulin. Emerg Med J 2010; 27:802–803.
  • Agarwal A, Yu SW, Rehman A, Henkle JQ. Hyperinsulinemia euglycemia therapy for calcium channel blocker overdose: a case report. Tex Heart Inst J 2012; 39:575–578.
  • Azendour H, Belyamani L, Atmani M, Balkhi H, Haimeur C. Severe amlodipine intoxication treated by hyperinsulinemia euglycemia therapy. J Emerg Med 2010; 38:33–35.
  • Clark EG, Nykamp DL, Nguyen VV. High-dose insulin in the treatment of antihypertensive overdose. Hosp Pharm 2008; 43: 206–209.
  • Cumpston KL, Rose SR. Titration of hyperinsulinemia euglycemia therapy for the treatment of acute diltiazem toxicity. Clin Toxicol 2009; 47:724.
  • Deshpande LMK. Diltiazem overdose haemodynamic response to hyperinsulinaemia-euglycaemia therapy: a case report. Crit Care Resusc 2004; 6:28–30.
  • El Houari T, Haddiya I, Ouafi NE, Bazid Z. A survival case in a severe amlodipine intoxication. Case Rep Cardiol 2013; 2013:842606.
  • Goplani K, Gumber M, Kute V, Shah P, Trivedi H, Vanikar A. Successful treatment of refractory hypotension, noncardiogenic pulmonary edema and acute kidney injury after an overdose of amlodipine. Indian J Crit Care Med 2011; 15:182.
  • Hadjipavlou G, Harfeez A, Messer B, Hughes T. Management of lercarnidipine overdose with hyperinsulinaemic euglycaemia therapy: case report. Scand J Trauma Resusc Emerg Med 2011; 19:8.
  • Harris NS. Case 24-2006: a 40-year-old woman with hypotension after an overdose of amlodipine. NEJM 2006; 355:602–611.
  • Hasin T, Leibowitz D, Antopolsky M, Chajek-Shaul T. The use of low-dose insulin in cardiogenic shock due to combined overdose of verapamil, enalapril and metoprolol. Cardiology 2006; 106: 233–236.
  • King A, Menke NB, Abesamis MG. Volume overload from institution of high dose insulin therapy for calcium channel blocker poisoning. Clin Toxicol 2013;51:575–724.
  • Maldonado I, Megan J, Amber C, Chadwick C. Beta-blockers and calcium-channel blockers overdose: time to abandon a silver-bullet approach. Crit Care Med 2012; 40:1182.
  • Marques I, Gomes E, Oliveira J. Treatment of calcium channel blocker intoxication with insulin infusion: case report and literature review. Resuscitation 2003; 57:211–213.
  • Montiel V, Gougnard T, Hantson P. Diltiazem poisoning treated with hyperinsulinemic euglycemia therapy and intravenous lipid emulsion. Eur J Emerg Med 2011; 18:121–123.
  • Munshi P, Puri N, Haroz R, Gerber D, Rajaram SS. A fatal case of prolonged hypotension following amlodipine and lisinopril overdose. Critical Care Medicine Conference: 40th Critical Care Congress of the Society of Critical Care Medicine San Diego, CA United States Conference Start: 20110115 Conference End: 20110119 Conference Publication: (var pagings) 2010; 38:A260.
  • Nickson CP, Little M. Early use of high-dose insulin euglycaemic therapy for verapamil toxicity. Med J Aust 2009; 191:350–352.
  • Nimbalkar SM, Patel DV. Near fatal case of amlodipine poisoning in an infant. Indian J Pediatr 2013; 80:513–515.
  • Ortiz-Nunoz L, Rodriguez-Ospina LF, Figueroa-Gonzalez M. Hyperinsulinemic-euglycemic therapy for intoxication with calcium channel blockers. Bol Assoc Med PR 2005; 97:182–189.
  • Patel NP, Pugh ME, Goldberg S, Eiger G. Hyperinsulinemic euglycemia therapy for verapamil poisoning: case report. AJCC 2007; 16:518–520.
  • Rosser G, Dubrey W. Massive calcium channel blocker overdose: intravenous insulin and glucose as a therapy. BMJ Case Rep 2012. doi:10.1136/bcr.03.2012.6114.
  • Stellpflug SJ, Cole JB, Fritzlar SJ, Engebretsen KM, Holger JS. Cardiotoxic overdose treated with intravenous fat emulsion and high-dose insulin in the setting of hypertrophic cardiomyopathy. J Med Toxicol 2011; 7:151–153.
  • St-Onge M. Bulletin d'information toxicologique 2010; 26:3–9.
  • Bouchard NC, Weinberg RL, Burkart KM, Bacchetta M, Dzierba A, Story D, et al. Prolonged resuscitation for massive amlodipine overdose with maximal vasopressors, intralipids and veno arterial- extracorporeal membrane oxygenation (VA ECMO). Clin Toxicol 2010; 48:613.
  • DeRita F, Barozzi L, Franchi G, Faggian G, Mazzuco A, Luciani GR. Rescue extracorporeal life support for acute verapamil and propranolol toxicity in a neonate. Artif Organs 2011; 35:416–420.
  • Holzer M, Sterz F, Schoerkhuber W, Behringer W, Domanovits H, Weinmar D, et al. Successful resuscitation of a verapamil-intoxicated patient with percutaneous cardiopulmonary bypass. Crit Care Med 1999; 27:2818–2823.
  • Kolcz J, Pietrzyk J, Januszewska K, Procelewska M, Mroczek T, Malec E. Extracorporeal life support in severe propranolol and verapamil intoxication. J Intensive Care Med 2007;22:381.
  • Maclaren G, Butt W, Cameron P, Preovolos A, McEgan R, Marasco S. Treatment of polypharmacy overdose with multimodality extracorporeal life support. Anaesth Intensive Care 2005; 33:120–123.
  • Persad E, Raman L, Thompson M, Sheeran P. The use of extracorporeal life support in adolescent amlodipine overdose. Indian J Crit Care Med 2012; 16:204–206.
  • Rona R, Cortinovis B, Marcolin R, Patroniti N, Isgro S, Marelli C, Fumagalli R. Extra-corporeal life support for near- fatal multi-drug intoxication: a case report. J Med Case Rep 2011; 5:231.
  • Rygnestad T, Moen S, Wahba A, Lien S, Ingul CB, Schrader H, Knapstad SE. Severe poisoning with sotalol and verapamil. Recovery after 4h of normothermic CPR followed by extra corporeal heart lung assist. Acta Anaesthesiol Scand 2005; 49: 1378–1380.
  • Schmidt W, Reissig M, Neuhaus KL. Percutaneous cardiopulmonary bypass for cardiogenic shock caused by poisoning with meltidigoxin, nifedipine and indapamide. Dtsch Med Wochenschr 1995; 120:996–1002.
  • Weinberg RL, Bouchard NC, Abrams DC, Bacchetta M, Dzierba AL, Burkart KM, Brodie D. Venoarterial extracorporeal membrane oxygenation for the management of massive amlodipine overdose. Perfusion 2014; 29:53–56.
  • Chimienti M, Previtalli M, Medici A, Piccinini M. Acute verapamil poisoning: successful treatment with epinephrine. Clin Cardiol 1982; 5:219–222.
  • Henderson A, Stevenson N, Hackett LP, Pond SM. Diltiazem overdose in an elderly patient: efficacy of adrenaline. Anaesth Intensive Care 1992; 20:507–510.
  • Kalman S, Berg S, Lisander B. Combined overdose with verapamil and atenolol: treatment with high doses of adrenergic agonists. Acta Anaesthesiol Scand 1998; 42:379–382.
  • Oe H, Taniura T, Ohgitani N. A case of severe verapamil overdose. Jpn Circ J 1998; 62:72–76.
  • Plumb JAM, Stewart C, Eddleston M, de Beer T. Prolonged refractory hypotension following combined amlodipine and losartan ingestion responsive to metaraminol. Case Rep Med 2011; Article ID 283672.
  • Proano L, Chiang WK, Wand RY. Calcium channel blocker overdose. Am J Emerg Med 1995; 13:444–450.
  • Roberts D, Pharm NH, Sitar DS, Tenenbein M. Diltiazem overdose: pharmacokinetics of diltiazem and its metabolites and effect of multiple dose charcoal therapy. Clin Toxicol 1991; 29:45–52.
  • Fant JS, James LP, Fiser RT, Kearns GL. The use of glucagon in nifedipine poisoning complicated by clonidine ingestion. Ped Emerg Care 1997; 13:417–419.
  • Fung HT, Lai CH, Wong OF, Lam KK, Kam CW. The use of glucagon and other antidotes in a case of beta-blocker and calcium channel blocker overdose. Hong Kong J Emerg Med 2007; 14: 113–118.
  • Motokawa K, Takahashi H, Ohashi N, Sato S, Naito H. Poisoning caused by the combined ingestion of nifedipine and metoprolol. J Toxicol Clin Toxicol 1993; 31:631–637.
  • Papadopoulos J, O’Neil M. Utilization of a glucagon infusion in the management of a massive nifedipine overdose. J Emerg Med 2000; 18:453–455.
  • Wolf LR, Spadafora MP, Otten EJ. Use of Amrinone and glucagon in a case of calcium channel blocker overdose. Ann Emerg Med 1993; 22:150–152.
  • Akinci E, Koylu R. Verapamil poisoning, the importance of intravenous lipid therapy: Case report. Akademik Acil Tip Olgu Sunumlari Dergisi. 2013;4:130–132.
  • Al-Nabhan M. Lipid emulsion therapy for verapamil overdose. Chest 2011; 140:184A (meeting abstract)
  • Armenian P, French D, Smollin C, Olson KR, Wu AHB. Prolonged absorption from a sustained-release verapamil preparation with documentation of serum levels and their response to intralipid. Clin Toxicol 2010; 48:646.
  • Assink MAJ, Spronk PE, van Kan HJM, Braber A. Intravenous lipid emulsion in the treatment of verapamil intoxication. Neth J Crit Care 2013;17:18–21.
  • Bologa C, Lionte C, Coman A, Sorodoc L. Lipid emulsion therapy in cardiodepressive syndrome after diltiazem overdose–case report. Am J Emerg Med 2013;31:1154.e3–4.
  • Chandrashekar H, Lambert M, George P. Calcium channel blocker poisoning. Acute Med 2011; 10:223–224.
  • Cooper G, Dyas J, Krishma CV, Thompson JP. Successful use of intravenous fat emulsion in severe poisoning following ingestion of lipid soluble drugs. Clin Toxicol 2010; 48:298.
  • French D, Armenian P, Ruan W, Wong A, Drasner K, Olson KR, Wu AHB. Serum verapamil concentrations before and after Intralipid therapy during treatment of an overdose. Clin Toxicol 2011; 49:340–344.
  • Gonzales J, Meaney C, Sareh H, Hayes B. Intravenous lipid emulsion for amlodipine overdose. Crit Care Med 2012;1:309–310.
  • Liang CW, Diamond SJ, Hagg DS. Lipid rescue of massive verapamil overdose: a case report. J Med Case Rep 2011; 5:399.
  • Meaney C, Sareh H, Hayes B, Gonzales J. Intravenous lipid emulsion in the management of amlodipine overdose. Hosp Pharm 2013;48:848–854.
  • Oakes JA, Piquette C, Barthold CL. Successful use of intravenous lipid as adjunctive therapy in a severe calcium channel antagonist poisoning. Clin Toxicol 2009; 47:755–756.
  • Orr K, Bailie R. The use of intralipid in the management of a mixed overdose. JICS 2010; 11:268–269.
  • Wilson BJ, Cruikshank JS, Wiebe KL, Dias VC, Yarema MC. Intravenous lipid emulsion therapy for sustained release diltiazem poisoning: a case report. J Popul Ther Clin Pharmacol 2012; 19:e218–e222.
  • Young AC, Velez Ll, Kleinschmidt KC. Intravenous fat emulsion therapy for intentional sustained-release verapamil overdose. Resuscitation 2009; 80:591–593.
  • Stellpflug SJ, Cole JB, Fritzlar SJ, Engebretsen KM, Holger JS. Overdose of diltiazem, metoprolol and amiodarone treated successfully with intravenous fat emulsion and high dose insulin in a awake patient. Clin Toxicol 2010; 48:612.
  • Osthoff M, Bernsmeier C, Marsch SC, Hunziker PR. Levosimendan as treatment option in severe verapamil intoxicaion: a case report and review of the literature. Case Rep Med 2010; Article ID 546904.
  • Sencan A, Adanir T, Terzi G, Atay A, Karahan N. Treatment of calcium channel blocker overdose with levosimendan. Crit Care 2011; 15:P95.
  • Teker MG, Ozdemir H, Saidoglu L, Erkalp K, Basaranoglu G. Levosimendan as a rescue adjunct in amlodipine intoxication. Middle Eeast J Anesthesiol 2010; 20:869–872.
  • Goenen M, Col J, Compere A, Bonte J. Treatment of severe verapamil poisoning with combined amrinone-isoproterenol therapy. Am J Cardiol 1986; 58:1142–1143.
  • Franxman TJ, Al-Nabhan M, Cavallazzi RS. Lipid emulsion therapy for verapamil overdose. Ann Int Med 2011; 154:292.
  • St-Onge M, Amjo I, Poirier D, Laliberté M. L-carnitine for the treatment of a calcium channel blocker and metformin poisoning. J Med Toxicol 2013;9:266–269.
  • Luomanmäki K, Tiula E, Kivistö KT, Neuvonen PJ. Pharmacokinetics of diltiazem in massive overdose. Ther Drug Monit 1997; 19:240–242.
  • Harley C, Kannan S, Morrow B. Combined overdose with bisoprolol, nifedipine and diltiazem. Care Crit Ill 2001; 17.
  • Deters M, Friesecke S, Hentschel H. Fatal poisoning caused by felodipine. Clin Toxicol 2010; 48:281.
  • Januszewska K, Kolcz J, Malec E, Mroczek T, Pietrzyk J, Procelewska M. Extracorporeal life support in severe propranolol and verapamil intoxication. J Intensive Care Med 2007; 22:381.
  • Sztajnkrycer MD, Bond GR, Johnson SB, Weaver AL. Use of vasopressin in a canine model of severe verapamil poisoning: a preliminary descriptive study. Acad Emerg Med 2004; 11: 1253–1261.
  • Lee DC, Greene T, Dougherty T, Pearigen P. Fatal nifedipine ingestions in children. J Emerg Med 2000; 19:359–361.
  • Jaeger A, Haubenstock H, Gossinge K, Pirich A, Donner U, Lruby K. Acute intoxication with calcium channel blocker verapamil, a study of 11 cases. Intensive Care 1984; 9:74–77.
  • Kruger P. Suicide attempt with verapamil. Therapiewoche 1984; 34:2483–2491.
  • Frese JH, Rohland L, Schulz M, Schmoldt A. Intoxication with the calcium antagonist Gallopamil: Course and treatment. Dtsch Med Wochenschr 1988; 113:770–772.
  • Frierson J, Bailly D, Shultz T, Sund S, Dimas A. Refractory cardiogenic shock and complete heart block after unsuspected verapamil-SR and atemolol overdose. Clin Cardiol 1991; 14:933–935.
  • Jovic-Stosic J, Djordjevic S, Putic V, Vicunic S, Perkovic-Vukcevic N, Vukovic-Ercegovic G. Lipid emulsion in treatment of verapamil and benzodiazepine toxicity: Clinical effects and serum concentrations. Clin Toxicol 2012; 50:363.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.